First Research Study of the Possible New Medicine NNC0113-2023 in Healthy Men.

NCT03617081 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: NNC0113-2023
DRUG: Placebo (NNC0113-2023)

Sponsor

Novo Nordisk A/S